Institute of Medical Sciences, University of Tokyo

About

The Institute of Medical Sciences at the University of Tokyo is one of the most authoritative medical research institutions in Japan. It has jurisdiction over many world-class laboratories such as the Cancer Research Institute, the Genomic Medicine Center, and the Stem Cell Therapy Research Center, and has achieved many milestone results in the fields of cancer immunotherapy, gene editing, and regenerative medicine. Working closely with the University of Tokyo Affiliated Hospital, it undertakes many national-level rare disease research projects in Japan and is the core base for genetic diagnosis and treatment of rare diseases in Asia.

Highlights

亚洲领先医学研究所，iPS细胞与癌症免疫治疗先驱

Specialties

• cancer immunotherapy
• Genomic Medicine
• regenerative medicine
• gene therapy
• rare disease studies
• stem cell research
• Infection research
• personalized medicine

Achievements

• Successfully developed the world's first clinical application plan for iPS cells
• Important breakthroughs have been made in CAR-T cell treatment of solid tumors
• Multiple cancer susceptibility genes associated with Asian populations were found
• Undertake multiple national-level medical research projects of AMED Japan
• Published more than 50 papers every year in top journals such as Nature and Science